These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 2478631

  • 1. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.
    Gao XM, Liew FY, Tite JP.
    J Immunol; 1989 Nov 01; 143(9):3007-14. PubMed ID: 2478631
    [Abstract] [Full Text] [Related]

  • 2. A dominant Th epitope in influenza nucleoprotein. Analysis of the fine specificity and functional repertoire of T cells recognizing a single determinant.
    Gao XM, Liew FY, Tite JP.
    J Immunol; 1990 Apr 01; 144(7):2730-7. PubMed ID: 1690775
    [Abstract] [Full Text] [Related]

  • 3. Both H-2- and non-H-2-linked genes influence influenza nucleoprotein epitope recognition by CD4+ T cells.
    Brett SJ, Tite JP.
    Immunology; 1996 Jan 01; 87(1):42-8. PubMed ID: 8666434
    [Abstract] [Full Text] [Related]

  • 4. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM, Turner RV, Biddison WE, Coligan JE.
    J Immunol; 1992 Feb 01; 148(3):894-9. PubMed ID: 1370522
    [Abstract] [Full Text] [Related]

  • 5. Comparison of class I- and II-restricted T cell recognition of the identical peptide.
    Perkins DL, Berriz G, Wang YS, Smith JA, Gefter ML.
    Eur J Immunol; 1991 Nov 01; 21(11):2781-9. PubMed ID: 1718759
    [Abstract] [Full Text] [Related]

  • 6. Selection of the same major T cell determinants of influenza nucleoprotein after vaccination or exposure to infectious virus.
    Brett SJ, Gao XM, Liew FY, Tite JP.
    J Immunol; 1991 Sep 01; 147(5):1647-52. PubMed ID: 1715366
    [Abstract] [Full Text] [Related]

  • 7. Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides.
    Gao XM, Zheng B, Liew FY, Brett S, Tite J.
    J Immunol; 1991 Nov 15; 147(10):3268-73. PubMed ID: 1682377
    [Abstract] [Full Text] [Related]

  • 8. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
    Oukka M, Manuguerra JC, Livaditis N, Tourdot S, Riche N, Vergnon I, Cordopatis P, Kosmatopoulos K.
    J Immunol; 1996 Oct 01; 157(7):3039-45. PubMed ID: 8816413
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells.
    Kos FJ, Müllbacher A.
    Eur J Immunol; 1992 Jun 01; 22(6):1595-601. PubMed ID: 1376266
    [Abstract] [Full Text] [Related]

  • 15. In vivo administration of major histocompatibility complex class I-specific peptides from influenza virus induces specific cytotoxic T cell hyporesponsiveness.
    Müllbacher A, Tha Hla R.
    Eur J Immunol; 1993 Oct 01; 23(10):2526-31. PubMed ID: 8405053
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun 01; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.